Recursion Pharmaceuticals
RXRX
#4226
Rank
C$2.72 B
Marketcap
$6.78
Share price
-9.07%
Change (1 day)
-43.89%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2024 (TTM): -C$0.65 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are C$58.48 Million. a decrease over its 2023 earnings that were of -C$0.47 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -C$0.66 Billion39.51%
2023 -C$0.47 Billion38.68%
2022 -C$0.34 Billion30.46%
2021 -C$0.26 Billion114.28%
2020 -C$0.13 Billion